Thaysa Walléria de Aragão Santos

Thaysa Walléria de Aragão Santos

Auto-generated profile, based on publicly available information

Thaysa Walléria de Aragão Santos

Grupo de Bioinformática e prospecção molecular, Laboratório de Imunopatologia Keizo Asami, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
AIAlinny Rosendo Isaac
Alinny Rosendo Isaac
PVPatricia Coelho de Velasco
Patricia Coelho de Velasco
KFKarla Yasmin Dias Fraga
Karla Yasmin Dias Fraga
MTMaria das Graças Tavares-Do-Carmo
Maria das Graças Tavares-Do-Carmo
RCRaquel Maria Pereira Campos
Raquel Maria Pereira Campos
Ricardo Augusto de Melo ReisRicardo Augusto de Melo Reis
Ricardo Augusto de Melo Reis

21 May 2024
Verified
Book Chapter
Open access
PDF file
DMDanyelly Martins
Danyelly Martins
TSThaysa Walleria Aragão Santos
Thaysa Walleria Aragão Santos
MAMaria Helena Menezes Estevam Alves
Maria Helena Menezes Estevam Alves
RARosângela Ferreira Frade de Araújo
Rosângela Ferreira Frade de Araújo
Metabolic syndrome includes several diseases that are associated with metabolic abnormalities such as obesity, dyslipidemia, hypertension, type 2 diabetes, obesity, cardiac diseases, and insulin resistance. In order to maintain cellular homeostasis, it is necessary to regulate the signaling pathways involved in controlling oxidative stress. Nuclear factor erythroid-2 factor 2 (NRF2) is a transcription factor largely expressed in several tissues and cells and participates in the oxidative stress regulation signaling pathways. NRF2 also mediates transcriptional regulation of a variety of target genes to signalize and regulate acute and chronic stress pathways in metabolic syndrome. Deregulation of NRF2 could contribute to a worst prognosis/profile of individuals with metabolic syndrome. Therefore, NRF2 and its activators might play a role in its treatment, highlighted as targets for modulation by pharmacological agents.

15 October 2020 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
TSThaysa Walléria de Aragão Santos
Thaysa Walléria de Aragão Santos
ACAndriu dos Santos Catena
Andriu dos Santos Catena
SMSandra da Silva Mattos
Sandra da Silva Mattos
JFJosé Luiz de Lima Filho
José Luiz de Lima Filho
DMDanyelly Martins
Danyelly Martins